Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Montserrat Royo"'
Autor:
Julia Oto, Álvaro Fernández-Pardo, Pilar Medina, Laura Martos, Manuel Martinez, Montserrat Royo, David Hervás, Silvia Navarro, Mary J. Heeb, Francisco España, César D. Vera-Donoso
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-10 (2020)
Scientific Reports
Scientific Reports
The diagnostic specificity of prostate specific antigen (PSA) is limited. We aimed to characterize eight anti-PSA monoclonal antibodies (mAbs) to assess the prostate cancer (PCa) diagnostic utility of different PSA molecular forms, total (t) and free
Publikováno v:
Archives of Biochemistry and Biophysics. 434:266-274
Tyrosine hydroxylase is phosphorylated at four serine residues in its amino-terminus by multiple kinases. Phosphorylation of serine 40 by cAMP-dependent protein kinase results in alleviation of dopamine inhibition [J. Biol. Chem. 267 (1992) 12639]. T
Publikováno v:
Proteins: Structure, Function, and Bioinformatics. 58:14-21
Tyrosine hydroxylase (TyrH) catalyzes the conversion of tyrosine to dihydroxyphenylalanine (DOPA), the rate-limiting step in the biosynthesis of dopamine. Four mutations in the TyrH gene have recently been described in cases of autosomal recessive DO
Publikováno v:
Archives of Biochemistry and Biophysics. 423:247-252
Short-term regulation of catecholamine biosynthesis involves reversible phosphorylation of several serine residues in the N-terminal regulatory domain of tyrosine hydroxylase. The MAP kinases ERK1/2 have been identified as responsible for phosphoryla
Autor:
Francisco España, César D. Vera, Silvia Navarro, Jose M Alapont, Amparo Estellés, Justo Aznar, Manuel Martinez, Juan F. Jiménez-Cruz, Montserrat Royo
Publikováno v:
Clinical Chemistry. 48:1251-1256
Background: The aim of this study was to assess the diagnostic accuracy of the proportion of prostate-specific antigen (PSA) complexed to α1-antichymotrypsin (PSA-α1ACT:PSA ratio) in the differential diagnosis of prostate cancer (CaP) and benign pr
Autor:
Francisco España, Manuel Martínez-Sarmiento, J. Oto, Montserrat Royo, Laura Martos, S. Navarro, L.A. Ramón, C.D. Vera Donoso, J.M. Alapont, P. Medina-Badenes
Publikováno v:
European Urology Supplements. 16:e615
Autor:
F. Peinado, C.D. Vera Donoso, M Martínez Sarmiento, Justo Aznar, Amparo Estellés, Francisco España, Montserrat Royo, J.F. Jiménez Cruz, J.M. Alapont
Publikováno v:
Actas Urológicas Españolas. 25:350-356
Resumen objetivos Evaluar la influencia que sobre el cociente C/T tiene factores como la edad, el volumen prostatico, la concentracion serica de PSA total, el estadio clinico y el Gleason Material y metodos Determinamos, con ensayos de desarrollo pro
Autor:
Francisco España, Justo Aznar, M Martínez Sarmiento, C.D. Vera Donoso, Montserrat Royo, J.F. Jiménez Cruz, Amparo Estellés, Pilar Medina
Publikováno v:
Actas Urológicas Españolas. 25:269-277
Resumen Objetivo Evaluar la utilidad del cociente formado por el complejo PSA: α1-antiquimotripsina (PSA: α1-ACT) y el PSA total (cociente C/T) en el diagnostico del cancer de prostata (CaP), en el rango de PSA total entre 4 y 10 ng/ml Material y m
Prostate–Specific Antigen Complexed to α1–Antichymotrypsin in the Early Detection of Prostate Cancer
Autor:
Francisco España, Pilar Medina, J. Fernando Jimenez-Cruz, Justo Aznar, César D. Vera, Amparo Estellés, Manuel Martinez, Montserrat Royo
Publikováno v:
European Urology. 38:85-90
Objectives: To study the usefulness of the complexed–to–total (C:T) prostate–specific antigen (PSA) ratio in the early detection of prostate cancer in patients with a total PSA valu
Publikováno v:
THROMBOSIS AND HAEMOSTASIS
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
SummaryThe ability of unfractionated (UF) heparin and low-molecular-weight heparin (LMWH) to potentiate the inhibition of fibrinolytic and coagulation factors by protein C inhibitor (PCI) was studied. Inhibition of activated protein C (APC), urokinas